KR950702530A - 프로스타글란딘 유도체 - Google Patents
프로스타글란딘 유도체 Download PDFInfo
- Publication number
- KR950702530A KR950702530A KR1019950700118A KR19950700118A KR950702530A KR 950702530 A KR950702530 A KR 950702530A KR 1019950700118 A KR1019950700118 A KR 1019950700118A KR 19950700118 A KR19950700118 A KR 19950700118A KR 950702530 A KR950702530 A KR 950702530A
- Authority
- KR
- South Korea
- Prior art keywords
- expression
- salt
- carbon atoms
- alkyl group
- hydrogen atom
- Prior art date
Links
- 150000003180 prostaglandins Chemical class 0.000 title claims abstract 5
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 1
- 230000000302 ischemic effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
목적 : 우수한 혈소판 응집억제작용을 갖는 신규한 PG 유도체를 제공한다.
구성 : 식
로 표시되는 프로스타글란딘 유도체 및 그의 염.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (3)
- 식(식중, R은 수소원자 또는 탄소원자수 1∼6개의 알킬기를 나타낸다)로 표시되는 프로스타글란딘 유도체 및 그의 염.
- 식(식중, R은 수소원자 또는 탄소원자수 1∼6개의 알킬기를 나타낸다)로 표시되는 프로스타글란딘 유도체 및 그의 염을 유효성분으로 하는 신질환 개선제.
- 식(식중, R은 수소원자 또는 탄소원자수 1∼6개의 알킬기를 나타낸다)로 표시되는 프로스타글란딘 유도체 및 그의 염을 유효성분으로 하는 허혈성 신질환 또는 심부전 개선제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP92-198556 | 1992-07-24 | ||
JP198556/1992 | 1992-07-24 | ||
JP19855692 | 1992-07-24 | ||
PCT/JP1993/000938 WO1994002457A1 (en) | 1992-07-24 | 1993-07-08 | Prostaglandin derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
KR950702530A true KR950702530A (ko) | 1995-07-29 |
KR100266834B1 KR100266834B1 (ko) | 2000-09-15 |
Family
ID=16393150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950700118A KR100266834B1 (ko) | 1992-07-24 | 1993-07-08 | 프로스타글란딘 유도체 |
Country Status (6)
Country | Link |
---|---|
US (1) | US5491254A (ko) |
EP (1) | EP0652211A1 (ko) |
KR (1) | KR100266834B1 (ko) |
AU (1) | AU664915B2 (ko) |
CA (1) | CA2140853A1 (ko) |
WO (1) | WO1994002457A1 (ko) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL87116A (en) | 1987-07-17 | 1993-03-15 | Schering Ag | 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same |
CA2140853A1 (en) * | 1992-07-24 | 1994-02-03 | Takehiro Amano | Prostaglandin derivatives |
EP0666256A1 (en) * | 1992-10-20 | 1995-08-09 | Taisho Pharmaceutical Co. Ltd | Prostaglandine derivative |
WO1996016935A1 (fr) * | 1994-11-30 | 1996-06-06 | Taisho Pharmaceutical Co., Ltd. | Derive de prostaglandines |
US5599838A (en) * | 1996-02-23 | 1997-02-04 | Taisho Pharmaceutical Co., Ltd. | Prostaglandin derivatives |
EP1082961B1 (en) * | 1998-05-25 | 2006-01-25 | Taisho Pharmaceutical Co., Ltd | Sleep inducing agent comprising prostaglandin derivatives |
US7273883B2 (en) * | 2000-09-14 | 2007-09-25 | Allergan, Inc. | Prostaglandin EP4 antagonist |
US7217725B2 (en) * | 2000-09-14 | 2007-05-15 | Allergan, Inc. | Prostaglandin D2 antagonist |
US20040266880A1 (en) * | 2002-02-22 | 2004-12-30 | Fumie Sato | Antipruritics |
US7737182B2 (en) | 2002-08-09 | 2010-06-15 | Taisho Pharmaceutical Co., Ltd. | Pharmaceuticals for xerosis |
MXPA04004371A (es) * | 2002-08-09 | 2004-08-13 | Taisho Pharmaceutical Co Ltd | Agente antipruritico. |
WO2004043471A1 (ja) * | 2002-11-13 | 2004-05-27 | Taisho Pharmaceutical Co., Ltd. | 鎮痒剤 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204371A (en) * | 1979-12-10 | 1993-04-20 | Schering Aktiengesellschaft | Pharmaceutically active 9-chloroprostaglandins |
DE2950027A1 (de) * | 1979-12-10 | 1981-06-11 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel |
US4529812A (en) * | 1983-02-02 | 1985-07-16 | G. D. Searle & Co. | 3-Oxaprostaglandins |
IL87116A (en) * | 1987-07-17 | 1993-03-15 | Schering Ag | 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same |
KR100205279B1 (ko) * | 1991-04-22 | 1999-07-01 | 우에하라 아끼라 | 프로스타글란딘 이1 유연체 |
CA2140853A1 (en) * | 1992-07-24 | 1994-02-03 | Takehiro Amano | Prostaglandin derivatives |
DK0656889T3 (da) * | 1992-08-31 | 1999-03-22 | Schering Ag | 9-chlorprostaglandinestere og -amider og deres anvendelse ved fremstilling af lægemidler |
EP0666256A1 (en) * | 1992-10-20 | 1995-08-09 | Taisho Pharmaceutical Co. Ltd | Prostaglandine derivative |
JP3664488B2 (ja) * | 1993-02-19 | 2005-06-29 | 大正製薬株式会社 | 13,14−ジデヒドロプロスタグランジンe類の中間体の製造方法 |
-
1993
- 1993-07-08 CA CA002140853A patent/CA2140853A1/en not_active Abandoned
- 1993-07-08 KR KR1019950700118A patent/KR100266834B1/ko not_active IP Right Cessation
- 1993-07-08 WO PCT/JP1993/000938 patent/WO1994002457A1/ja not_active Application Discontinuation
- 1993-07-08 AU AU45137/93A patent/AU664915B2/en not_active Ceased
- 1993-07-08 EP EP93914970A patent/EP0652211A1/en not_active Ceased
-
1995
- 1995-01-19 US US08/373,226 patent/US5491254A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU664915B2 (en) | 1995-12-07 |
EP0652211A4 (en) | 1995-03-14 |
CA2140853A1 (en) | 1994-02-03 |
KR100266834B1 (ko) | 2000-09-15 |
EP0652211A1 (en) | 1995-05-10 |
US5491254A (en) | 1996-02-13 |
WO1994002457A1 (en) | 1994-02-03 |
AU4513793A (en) | 1994-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890014492A (ko) | 5-하이드록시피라졸 유도체 | |
KR930703303A (ko) | 1, 4-벤조티아제핀 유도체 | |
KR950701640A (ko) | 에리트로마이신 유도체(eryhromycin derivative) | |
KR950702530A (ko) | 프로스타글란딘 유도체 | |
KR880013937A (ko) | 옥세타노신 유도체 | |
KR940005274A (ko) | 쇼그렌(Sjoegren)증후군 치료제 | |
KR890007730A (ko) | 허혈성 심질환 치료제 | |
KR960007592A (ko) | 신규한 피롤로카바졸 | |
KR930703292A (ko) | 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제 | |
KR900001643A (ko) | 항균제 | |
KR860700250A (ko) | 신규 아미딘 화합물 | |
KR890008148A (ko) | 새로운 세파로스포린 화합물 및 항균제 | |
KR840007396A (ko) | 2-플루오로에톡시-치환된 벤젠 유도체의 제조방법 | |
KR960700245A (ko) | 메토트렉세이트 유도체[methotrexate derivative] | |
KR850005228A (ko) | 살균제인 아미노알칸포스폰산 및 그 유도체 | |
KR890003718A (ko) | N- 알킬벤젠 술포닐 카르바모일-5- 클로로이소티아졸 유도체 및 살미생물제 | |
DK455285D0 (da) | 2-pyridin-thiolderivater | |
KR890008151A (ko) | 키놀린 카르복산의 유도체 | |
KR900002781A (ko) | 동물용 항균제 | |
KR890009876A (ko) | 9-아실아미노- 테트라히드로아크리딘 유도체 및 그 유도체를 활성성분으로 포함하는 기억력 촉진제 | |
KR840008012A (ko) | 아미노에틸-피리딘 및 -피라진유도체의 제조방법 | |
KR920004334A (ko) | 광학적 활성 알라닌아닐리드 화합물의 산부가염 및 그것을 함유하는 약학적조성물 | |
KR920019734A (ko) | 페닐술포닐알칸산 화합물 | |
KR910005865A (ko) | 혈압강하제 | |
KR890005087A (ko) | 4- 피페리딘 카르복사미드 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |